Search research articles
Contact Us
Filters
Showing results (211-220 of 303) with videos related to
Page
of 31
Sort By:
Leukemia & Lymphoma
|
February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
Cancer
|
August 19, 2007
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells
Michael W N Deininger, Jorge Cortes, Ron Paquette, et al.
Arthritis Care & Research
|
November 12, 2015
Reply
Janet E Pope, Naomi F Rothfield, Rosalind Ramsey-Goldman, et al.
British Journal of Haematology
|
May 19, 2012
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias
Amer M Zeidan, Rebecca M Ricklis, Hetty E Carraway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias
Judith E Karp, Antonino Passaniti, Ivana Gojo, et al.
Blood
|
January 21, 2012
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia
Jonathan M Gerber, B Douglas Smith, Brownhilda Ngwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2022
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations
Daniel A Pollyea, Courtney D DiNardo, Martha L Arellano, et al.
Science Translational Medicine
|
June 12, 2015
Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia
Yiting Lim, Lukasz Gondek, Li Li, et al.
Leukemia Research
|
December 8, 2009
Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Judith E Karp, Amanda Blackford, B Douglas Smith, et al.
Blood
|
March 24, 2005
Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine
Ruben A Mesa, David Loegering, Heather L Powell, et al.
Page
of 31
Search research articles
Search
Showing results (211-220 of 303) with videos related to
Sort By:
Page
of 31
Leukemia & Lymphoma
|
February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
Cancer
|
August 19, 2007
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells
Michael W N Deininger, Jorge Cortes, Ron Paquette, et al.
Arthritis Care & Research
|
November 12, 2015
Reply
Janet E Pope, Naomi F Rothfield, Rosalind Ramsey-Goldman, et al.
British Journal of Haematology
|
May 19, 2012
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias
Amer M Zeidan, Rebecca M Ricklis, Hetty E Carraway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias
Judith E Karp, Antonino Passaniti, Ivana Gojo, et al.
Blood
|
January 21, 2012
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia
Jonathan M Gerber, B Douglas Smith, Brownhilda Ngwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2022
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations
Daniel A Pollyea, Courtney D DiNardo, Martha L Arellano, et al.
Science Translational Medicine
|
June 12, 2015
Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia
Yiting Lim, Lukasz Gondek, Li Li, et al.
Leukemia Research
|
December 8, 2009
Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Judith E Karp, Amanda Blackford, B Douglas Smith, et al.
Blood
|
March 24, 2005
Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine
Ruben A Mesa, David Loegering, Heather L Powell, et al.
Page
of 31